{"id":"https://openalex.org/W960376","doi":null,"title":"[Cognitive disturbances observed in chronic hepatitis C patients during pegylated interferon alpha and ribavirin therapy].","display_name":"[Cognitive disturbances observed in chronic hepatitis C patients during pegylated interferon alpha and ribavirin therapy].","publication_year":2008,"publication_date":"2008-11-01","ids":{"openalex":"https://openalex.org/W960376","mag":"960376","pmid":"https://pubmed.ncbi.nlm.nih.gov/19441669"},"language":"pl","primary_location":{"id":"pmid:19441669","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19441669","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria polska","raw_type":"Controlled Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038875827","display_name":"Tomasz Pawe\u0142czyk","orcid":"https://orcid.org/0000-0002-1421-2050","observed_orcids":["https://orcid.org/0000-0002-1421-2050"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Tomasz Pawe\u0142czyk","raw_affiliation_strings":["Klinika Zaburze\u0144 Afektywnych, Psychotycznych i Psychiatrii M\u0142odziezowej UM w \u0141odzi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinika Zaburze\u0144 Afektywnych, Psychotycznych i Psychiatrii M\u0142odziezowej UM w \u0141odzi","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051622348","display_name":"Agnieszka Maria Pawe\u0142czyk","orcid":"https://orcid.org/0000-0003-1900-0214","observed_orcids":["https://orcid.org/0000-0003-1900-0214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agnieszka Pawe\u0142czyk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051712335","display_name":"Jolanta Bia\u0142kowska","orcid":"https://orcid.org/0000-0002-2728-3456","observed_orcids":["https://orcid.org/0000-0002-2728-3456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jolanta Bia\u0142kowska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024429237","display_name":"Maciej Jab\u0142kowski","orcid":"https://orcid.org/0000-0002-3661-6777","observed_orcids":["https://orcid.org/0000-0002-3661-6777"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maciej Jab\u0142kowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084955711","display_name":"Dominik Strzelecki","orcid":"https://orcid.org/0000-0002-8559-1078","observed_orcids":["https://orcid.org/0000-0002-8559-1078"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominik Strzelecki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065761416","display_name":"Daniela Dworniak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Dworniak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5041434525","display_name":"Jolanta Rabe\u2010Jab\u0142o\u0144ska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jolanta Rabe-Jab\u0142o\u0144ska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"42","issue":"6","first_page":"925","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13077","display_name":"Cancer-related cognitive impairment studies","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.996999979019165},{"id":"https://openalex.org/keywords/pegylated-interferon-alpha","display_name":"pegylated interferon-alpha","score":0.9319999814033508},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.871999979019165},{"id":"https://openalex.org/keywords/attention","display_name":"attention","score":0.4560000002384186},{"id":"https://openalex.org/keywords/auditory-verbal-memory","display_name":"auditory-verbal memory","score":0.8009999990463257},{"id":"https://openalex.org/keywords/visuospatial-ability","display_name":"visuospatial ability","score":0.953000009059906},{"id":"https://openalex.org/keywords/neuropsychological-assessment","display_name":"neuropsychological assessment","score":0.8429999947547913},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6555304527282715},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.6379659175872803},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.6164658069610596},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.48262819647789},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47648781538009644},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.1602085530757904},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12997829914093018},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.12471649050712585},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001288","descriptor_name":"Attention","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008570","descriptor_name":"Memory, Short-Term","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011340","descriptor_name":"Problem Solving","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:19441669","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19441669","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria polska","raw_type":"Controlled Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W91500925","https://openalex.org/W144396922","https://openalex.org/W1231151993","https://openalex.org/W1523671473","https://openalex.org/W1534046497","https://openalex.org/W1966639644","https://openalex.org/W1981098067","https://openalex.org/W2003580954","https://openalex.org/W2016688965","https://openalex.org/W2020882728","https://openalex.org/W2021068986","https://openalex.org/W2021594711","https://openalex.org/W2022671065","https://openalex.org/W2024826669","https://openalex.org/W2039603323","https://openalex.org/W2068929498","https://openalex.org/W2071804866","https://openalex.org/W2073217474","https://openalex.org/W2073531245","https://openalex.org/W2073606662","https://openalex.org/W2075293916","https://openalex.org/W2078660110","https://openalex.org/W2087798692","https://openalex.org/W2088732481","https://openalex.org/W2090963721","https://openalex.org/W2092358120","https://openalex.org/W2127685726","https://openalex.org/W2134162261","https://openalex.org/W2148017192","https://openalex.org/W2155574232","https://openalex.org/W2171267694","https://openalex.org/W2411982058","https://openalex.org/W3171418018"],"related_works":["https://openalex.org/W2082488137","https://openalex.org/W2074256238","https://openalex.org/W2016078859","https://openalex.org/W2341206505","https://openalex.org/W7019147083","https://openalex.org/W2024826669","https://openalex.org/W7112201428","https://openalex.org/W2951711846","https://openalex.org/W3160021501","https://openalex.org/W2005791901"],"abstract_inverted_index":{"UNLABELLED:":[0],"Chronic":[1],"hepatitis":[2],"C":[3],"(CHC)":[4],"patients":[5,49,63,83,128,184,251],"treated":[6],"with":[7,26,163,187,259],"peg-interferon":[8],"alpha":[9],"and":[10,17,37,57,106,115,198,220,224,244],"ribavirin":[11],"(peg-IFNalpha/RBV)":[12],"complain":[13],"of":[14,30,40,97,119,166,182,207,255],"irritability,":[15],"attention":[16,243],"memory":[18,197],"disturbances":[19,42],"which":[20],"may":[21,203],"indicate":[22],"cognitive":[23,41,136,154,191,256],"impairment":[24],"associated":[25,258],"treatment.":[27,89],"AIM:":[28],"Assessment":[29],"the":[31,38,79,87,112,134,149,164,188,205,212,253],"probable":[32],"connection":[33],"between":[34],"peg-IFNalpha/RBV":[35,180,260],"treatment":[36,120],"development":[39],"in":[43,73,132,138,148,190,211,239],"CHC":[44,48,183],"patients.":[45],"METHOD:":[46],"47":[47],"were":[50,64],"divided":[51],"into":[52],"two":[53],"groups:":[54],"experimental":[55,61,126],"(n=26)":[56],"control":[58,150],"(n=21).":[59],"The":[60,125,152,176],"group":[62,82,127],"given":[65],"peg-IFNalpha2a":[66],"(n=18)":[67],"or":[68,121,236],"peg-IFNalpha2b":[69],"(n=8)":[70],"plus":[71],"RBV":[72],"standard":[74],"doses":[75],"as":[76],"recommended":[77],"by":[78],"manufacturers.":[80],"Control":[81],"did":[84],"not":[85,146,158],"receive":[86],"above":[88],"Both":[90],"groups":[91],"underwent":[92],"a":[93,231],"neuropsychological":[94],"examination":[95],"consisting":[96],"R.":[98],"Brickenkamp":[99],"d2":[100],"test,":[101],"Auditory":[102],"Verbal":[103],"Learning":[104],"Test":[105,110],"Hooper":[107],"Visual":[108],"Organization":[109],"at":[111],"beginning":[113],"(t=0)":[114],"after":[116],"12":[117],"weeks":[118],"observation":[122],"(t=1).":[123],"RESULTS:":[124],"showed":[129],"significant":[130],"deterioration":[131,189],"all":[133],"measured":[135],"functions":[137],"t=1":[139],"comparing":[140],"to":[141,172,229],"t=0.":[142],"Cognitive":[143],"decline":[144,257],"was":[145],"seen":[147],"group.":[151],"observed":[153],"performance":[155],"changes":[156,202],"could":[157],"be":[159,204],"correlated":[160],"sufficiently":[161],"enough":[162],"presence":[165],"organic":[167],"affective":[168],"disorders":[169],"diagnosed":[170],"according":[171],"ICD-10":[173],"criteria.":[174],"CONCLUSIONS:":[175],"findings":[177],"suggest":[178],"that":[179],"therapy":[181],"is":[185],"connected":[186],"functioning":[192],"including":[193],"attention,":[194],"auditory":[195],"verbal":[196],"visuo-spatial":[199],"skills.":[200],"These":[201],"effect":[206],"peg-IFNalpha-induced":[208],"neurotransmission":[209],"abnormalities":[210],"dorso-lateral":[213],"prefrontal":[214],"cortex,":[215,218],"anterior":[216],"cingulate":[217],"hippocampus":[219],"parieto-orbital":[221],"cortical":[222],"regions":[223],"can":[225],"impair":[226],"patients'":[227],"ability":[228],"drive":[230],"motor":[232],"vehicle,":[233],"operate":[234],"machinery,":[235],"their":[237],"engagement":[238],"hazardous":[240],"activities":[241],"requiring":[242],"coordination.":[245],"Medical":[246],"professionals":[247],"should":[248],"thoroughly":[249],"inform":[250],"about":[252],"possibility":[254],"therapy.":[261]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}